T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
TC Energy
TRP
$66.3B
| $585M | 0.05% |
12,560,590
+434,423
| +4% | +$21.5M |
|
327
AXIS Capital
AXS
$7.26B
| $581M | 0.05% |
10,658,742
-78,260
| -0.7% | -$4.05M |
|
328
Flowers Foods
FLO
$1.52B
| $581M | 0.05% |
21,132,685
-11,268
| -0.1% | -$291K |
|
329
Citigroup
C
$231B
| $579M | 0.05% |
9,586,259
-4,068,112
| -30% | -$270M |
|
330
Regeneron Pharmaceuticals
REGN
$82.2B
| $577M | 0.05% |
913,255
+103,415
| +13% | +$63.6M |
|
331
Cummins
CMI
$87.8B
| $576M | 0.05% |
2,638,885
+121,832
| +5% | +$27.8M |
|
332
American Electric Power
AEP
$67.9B
| $574M | 0.05% |
6,453,539
-2,130,153
| -25% | -$180M |
|
333
Deere & Co
DE
$167B
| $572M | 0.05% |
1,667,857
+817,726
| +96% | +$284M |
|
334
AT&T
T
$166B
| $566M | 0.05% |
30,477,063
-149,806
| -0.5% | -$2.8M |
|
335
SoFi Technologies
SOFI
$23.2B
| $558M | 0.05% |
35,272,640
-740,647
| -2% | -$13.6M |
|
|
SWAV
336
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $549M | 0.05% |
3,077,252
-142,722
| -4% | -$28.1M |
|
337
PTC
PTC
$16.1B
| $549M | 0.05% |
4,528,951
-54,619
| -1% | -$6.58M |
|
338
Imperial Oil
IMO
$63.1B
| $543M | 0.05% |
15,033,932
-4,482,263
| -23% | -$154M |
|
339
DraftKings
DKNG
$12.7B
| $543M | 0.05% |
19,750,185
-1,259
| -0% | -$49.3K |
|
340
Incyte
INCY
$24.5B
| $534M | 0.05% |
7,271,688
-11,638,526
| -62% | -$785M |
|
341
Caterpillar
CAT
$393B
| $532M | 0.05% |
2,571,959
-1,876,630
| -42% | -$378M |
|
342
nCino
NCNO
$2.08B
| $531M | 0.05% |
9,673,434
-3,630,128
| -27% | -$236M |
|
343
Opendoor
OPEN
$3.39B
| $528M | 0.05% |
37,375,293
+17,223,613
| +85% | +$318M |
|
344
Webster Financial
WBS
$12.8B
| $527M | 0.05% |
9,434,690
-586,812
| -6% | -$33M |
|
345
NiSource
NI
$20.1B
| $523M | 0.05% |
18,939,102
-22,096,738
| -54% | -$562M |
|
346
CubeSmart
CUBE
$9.28B
| $518M | 0.05% |
9,102,483
+364,302
| +4% | +$19.6M |
|
|
HCP
347
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $516M | 0.05% |
+5,733,516
| New | +$499M |
|
348
Element Solutions
ESI
$9.37B
| $510M | 0.05% |
21,001,323
+2,428
| +0% | +$57.3K |
|
349
Dentsply Sirona
XRAY
$2.27B
| $507M | 0.05% |
9,084,768
-10,114,115
| -53% | -$556M |
|
350
Verisk Analytics
VRSK
$23.5B
| $506M | 0.05% |
2,210,275
-19,323
| -0.9% | -$4.22M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.